Takuma Mihara

Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism.

Rosanna Sobota, Takuma Mihara, Alexandra D. Forrest et al. · Behavioral Neuroscience · 2015 · 83 citations · Full text

Life Sciences, Neuroscience, Psychology +13

Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: A comparison with diazepam and buspirone

Katsuya Harada, Masaki Aota, Tatsuo Inoue et al. · European Journal of Pharmacology · 2006 · 82 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors

Takuya Maemoto, Miho Tada, Takuma Mihara et al. · Journal of Pharmacological Sciences · 2004 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1 H)-one (ASP5854), in Models of Parkinson’s Disease and Cognition

Takuma Mihara, Kayoko Mihara, Junko Yarimizu et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 76 citations

Medicine, Neuroscience, Pharmacology +11

Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome

Naoki Kozono, Ai Okamura, Sokichi Honda et al. · Scientific Reports · 2020 · 54 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14